Medicine and Dentistry
ACE Inhibitor
10%
Acute Cardiac Care
15%
Acute Coronary Syndrome
20%
Acute Heart Infarction
36%
Antihypertensive Therapy
17%
Artery
25%
Artery Resistance
22%
Atenolol
7%
Biological Marker
28%
Blood Pressure
6%
Brain Natriuretic Peptide
7%
Bundle Branch Block
17%
Calcium Channel Blocking Agent
5%
Cardiac Resynchronization Therapy
5%
Cardiac Troponin
48%
Cardiology
34%
Cardiovascular Disease
8%
Cardiovascular System
56%
Clinical Trial
5%
Clinician
12%
Diagnosis
14%
Disease
8%
Electrocardiogram
6%
Essential Hypertension
29%
Heart Failure
5%
Heart Muscle Injury
48%
Heart Muscle Ischemia
19%
Heart Muscle Necrosis
5%
Infarction
10%
Injury
5%
Isradipine
9%
Left Ventricular Hypertrophy
17%
Myocardial Infarction
100%
Myocardium
6%
Non ST Segment Elevation Myocardial Infarction
6%
Noninferiority Trial
5%
Percutaneous Coronary Intervention
33%
Perindopril
13%
Revascularization
9%
ST Elevation
9%
ST Segment Elevation Myocardial Infarction
13%
Stable Angina Pectoris
5%
Sudden Cardiac Death
12%
Symptom
9%
Systolic Blood Pressure
5%
Thrombosis
8%
Triage
20%
Troponin
16%
Troponin T
22%
Unstable Angina Pectoris
11%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Coronary Syndrome
8%
Acute Heart Failure
6%
Acute Heart Infarction
39%
Adenosine A1 Receptor Antagonist
5%
Antihypertensive Agent
10%
Antihypertensive Therapy
6%
Atenolol
7%
Biological Marker
27%
Borane Derivative
5%
Brain Natriuretic Peptide
10%
Calcium Channel Blocker
5%
Cardiovascular Disease
5%
Chronic Kidney Failure
5%
Combination Therapy
6%
Comorbidity
8%
Copeptin
10%
Coronary Artery Disease
8%
Coronavirinae
5%
Dipeptidyl Carboxypeptidase
5%
Dipeptidyl Carboxypeptidase Inhibitor
5%
Disease
12%
Dobutamine
5%
Enzyme Inhibition
5%
Essential Hypertension
23%
Everolimus
5%
Heart Infarction
86%
Heart Left Ventricle Hypertrophy
7%
Heart Muscle Injury
37%
Heart Muscle Ischemia
16%
Heart Ventricle Arrhythmia
5%
Infarction
5%
Injury
5%
Isradipine
6%
Mortality Rate
5%
Non ST Segment Elevation Myocardial Infarction
6%
Noninferiority Trial
5%
Observational Study
5%
Out of Hospital Cardiac Arrest
5%
Perindopril
10%
Ramipril
5%
ST Segment Elevation Myocardial Infarction
10%
Stable Angina Pectoris
15%
Sudden Cardiac Death
5%
Telmisartan
5%
Thiazide Diuretic Agent
5%
Thrombosis
5%
Troponin
45%
Troponin I
10%
Troponin T
12%
Unstable Angina Pectoris
6%
Nursing and Health Professions
Acute Heart Infarction
21%
Angioplasty
5%
Area under the Curve
5%
Biological Marker
12%
Cardiac Myosin
5%
Clinical Practice
6%
Copeptin
5%
Coronary Care Unit
5%
Diagnosis
9%
Essential Hypertension
5%
Heart Failure
5%
Heart Infarction
44%
Heart Muscle Injury
18%
Heart Muscle Ischemia
5%
Heart Surgery
10%
Medical Decision Making
5%
Myosin Binding Protein C
5%
Non ST Segment Elevation Myocardial Infarction
5%
Out of Hospital Cardiac Arrest
5%
Percutaneous Coronary Intervention
10%
Resting Heart Rate
5%
ST Segment Elevation Myocardial Infarction
5%
Stable Angina Pectoris
5%
Sudden Cardiac Death
5%
Troponin
26%
Troponin I
8%
Troponin T
5%
Unstable Angina Pectoris
5%
